TOPO THERAPEUTICS Trademark

Trademark Overview

On Monday, July 15, 2024, a trademark application was filed for TOPO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the TOPO THERAPEUTICS trademark a serial number of 98649268. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Thursday, January 8, 2026. This trademark is owned by Topo Therapeutics, Inc.. The TOPO THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of pain disorders and folding disorders; pharmaceutical preparations, namely, a drug for the purpose of targeting ion channels and membrane transporters; pharmaceutical preparations, namely, a drug for the purpose of targeting ion channels and membrane transporters for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical preparations for the treatment of pain through activation of specific K+ channels in the peripheral nervous system; pharmaceutical preparations for the treatment of folding disorders via the detection of surface-expression of membrane proteins; all of the foregoing excluding biochemical laboratory kits for research activities involving gene cloning and expression
topo therapeutics

General Information

Serial Number98649268
Word MarkTOPO THERAPEUTICS
Filing DateMonday, July 15, 2024
Status730 - FIRST EXTENSION - GRANTED
Status DateThursday, January 8, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 25, 2025

Trademark Statements

NOT AVAILABLE"THERAPEUTICS"
Goods and ServicesPharmaceutical preparations for the treatment of pain disorders and folding disorders; pharmaceutical preparations, namely, a drug for the purpose of targeting ion channels and membrane transporters; pharmaceutical preparations, namely, a drug for the purpose of targeting ion channels and membrane transporters for use in pediatric, geriatric, emergency, family, and preventative medicine; pharmaceutical preparations for the treatment of pain through activation of specific K+ channels in the peripheral nervous system; pharmaceutical preparations for the treatment of folding disorders via the detection of surface-expression of membrane proteins; all of the foregoing excluding biochemical laboratory kits for research activities involving gene cloning and expression
Translation of Words in MarkThe English translation of the word "TOPO" in the mark is "mole".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 15, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameTopo Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWatertown, MA 02472-2802
Party NameTopo Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Monday, July 15, 2024NEW APPLICATION ENTERED
Thursday, November 21, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, November 21, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, November 21, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 21, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 21, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 15, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, January 28, 2025ASSIGNED TO EXAMINER
Wednesday, January 29, 2025NON-FINAL ACTION WRITTEN
Wednesday, January 29, 2025NON-FINAL ACTION E-MAILED
Wednesday, January 29, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 30, 2025EXAMINERS AMENDMENT -WRITTEN
Thursday, January 30, 2025EXAMINERS AMENDMENT E-MAILED
Thursday, January 30, 2025NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, January 30, 2025EXAMINER'S AMENDMENT ENTERED
Thursday, January 30, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 19, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 25, 2025PUBLISHED FOR OPPOSITION
Tuesday, February 25, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 26, 2025EXTENSION OF TIME TO OPPOSE RECEIVED
Sunday, July 6, 2025EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, August 12, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 12, 2025TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 12, 2025APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, August 12, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 18, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, November 19, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 19, 2025REVIEW OF CORRESPONDENCE COMPLETE
Thursday, September 18, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 20, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, January 8, 2026SOU TEAS EXTENSION RECEIVED
Thursday, January 8, 2026SOU EXTENSION 1 FILED
Thursday, January 8, 2026SOU EXTENSION 1 GRANTED
Friday, January 9, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 21, 2026TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, January 21, 2026DIVISIONAL REQUEST RECEIVED
Thursday, January 22, 2026DIVISIONAL PROCESSING COMPLETE
Thursday, January 22, 2026CORRECTED NOA E-MAILED

Related Keywords

therapeutics topo pharmaceutical preparations disorders treatment membrane channels expression targeting transporters purpose